Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share (OTLK)

Q: What does CUSIP 69012T305 represent in this 13F holders report?

CUSIP 69012T305 is the security identifier for OTLK - Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share used to aggregate holder disclosures.

Q: How many institutions held OTLK - Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share in Q4 2024?

60 institutional investors reported OTLK - Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share for Q4 2024. Use the holders table for investor-level position and value details.

CUSIP: 69012T305

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class: Equity / Common Stock, par value $0.01 per share
Shares outstanding: 120,049,038
Total 13F shares: 4,545,632
Share change: -3,423,426
Total reported value: $8,587,260
Put/Call ratio: 0.92%
Price per share: $1.89
Number of holders: 60
Value change: -$17,551,788
Number of buys: 36
Number of sells: 30

Quarterly Holders Quick Answers

What is CUSIP 69012T305?
CUSIP 69012T305 identifies OTLK - Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2025
Previous quarter: Q3 2024

Recent filing periods for CUSIP 69012T305:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of OTLK - Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Arun Kumar Pillai	3/4/5	Director, 10%+ Owner	— class O/S missing	22,982,529	$26,085,170	—	01 Feb 2022	3/4/5
Tenshi Healthcare Pte. Ltd.	3/4/5	10%+ Owner	— class O/S missing	22,982,529	$26,085,170	—	21 Apr 2022	3/4/5
TANG CAPITAL MANAGEMENT LLC	13F	Company	1.3%	1,559,560	$8,328,050	—	30 Sep 2024	13F
GREAT POINT PARTNERS LLC	13F	Company	1.1%	1,293,028	$6,904,770	—	30 Sep 2024	13F
BlackRock, Inc.	13F	Company	0.87%	1,044,988	$5,580,237	—	30 Sep 2024	13F
VANGUARD GROUP INC	13F	Company	0.71%	855,876	$4,570,378	—	30 Sep 2024	13F
Altium Capital Management LLC	13F	Company	0.45%	541,549	$2,891,872	—	30 Sep 2024	13F
TANG CAPITAL PARTNERS LP	13D/G	TANG CAPITAL MANAGEMENT, LLC	6.4%	1,682,502	$2,624,703	$0	31 Dec 2024	13D/G
Rosalind Advisors, Inc.	13F	Company	— class O/S missing	450,000	$2,403,000	—	30 Sep 2024	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.34%	413,545	$2,208,330	—	30 Sep 2024	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.28%	341,959	$1,826,403	—	30 Sep 2024	13F
Caligan Partners LP	13F	Company	0.27%	318,699	$1,701,853	—	30 Sep 2024	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.24%	285,714	$1,525,712	—	30 Sep 2024	13F
STATE STREET CORP	13F	Company	0.19%	232,542	$1,241,774	—	30 Sep 2024	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.13%	159,350	$850,929	—	30 Sep 2024	13F
Woodline Partners LP	13F	Company	0.13%	151,508	$809,053	—	30 Sep 2024	13F
Terry Dagnon	3/4/5	Chief Operations Officer	— mixed-class rows	845,201 mixed-class rows	$741,221	—	20 Apr 2023	3/4/5
Syntone Ventures LLC	3/4/5	10%+ Owner	— mixed-class rows	2,776,867 mixed-class rows	$716,284	—	15 Apr 2024	3/4/5
NORTHERN TRUST CORP	13F	Company	0.1%	118,869	$634,761	—	30 Sep 2024	13F
FEDERATED HERMES, INC.	13F	Company	0.08%	91,419	$488,177	—	30 Sep 2024	13F
Jeff Evanson	3/4/5	CHIEF COMMERCIAL OFFICER	— mixed-class rows	833,459 mixed-class rows	$339,553	—	20 Mar 2024	3/4/5
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.04%	51,459	$274,791	—	30 Sep 2024	13F
LVW Advisors, LLC	13F	Company	0.04%	47,730	$254,879	—	30 Sep 2024	13F
MORGAN STANLEY	13F	Company	0.04%	43,729	$233,512	—	30 Sep 2024	13F
XTX Topco Ltd	13F	Company	0.03%	37,328	$199,332	—	30 Sep 2024	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.03%	35,574	$189,965	—	30 Sep 2024	13F
SCOTIA CAPITAL INC.	13F	Company	0.03%	32,966	$176,039	—	30 Sep 2024	13F
Corton Capital Inc.	13F	Company	0.03%	31,162	$166,405	—	30 Sep 2024	13F
BARCLAYS PLC	13F	Company	0.02%	20,943	$111,836	—	30 Sep 2024	13F
Bank of New York Mellon Corp	13F	Company	0.02%	20,553	$109,751	—	30 Sep 2024	13F
Nuveen Asset Management, LLC	13F	Company	0.02%	20,079	$107,222	—	30 Sep 2024	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.01%	15,134	$80,816	—	30 Sep 2024	13F
RHUMBLINE ADVISERS	13F	Company	0.01%	13,154	$70,233	—	30 Sep 2024	13F
CITIGROUP INC	13F	Company	0.01%	12,336	$65,875	—	30 Sep 2024	13F
LPL Financial LLC	13F	Company	0.01%	11,560	$61,730	—	30 Sep 2024	13F
ExodusPoint Capital Management, LP	13F	Company	0.01%	11,235	$60,000	—	30 Sep 2024	13F
JANE STREET GROUP, LLC	13F	Company	0.01%	11,210	$59,861	—	30 Sep 2024	13F
GABLES CAPITAL MANAGEMENT INC.	13F	Company	0.01%	10,975	$58,607	—	30 Sep 2024	13F
Christensen, King & Associates Investment Services, Inc.	13F	Company	0.01%	10,276	$54,874	—	30 Sep 2024	13F
PNC FINANCIAL SERVICES GROUP, INC.	13F	Company	0.01%	10,000	$53,400	—	30 Sep 2024	13F
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	13F	Company	0.01%	8,286	$44,247	—	30 Sep 2024	13F
Corebridge Financial, Inc.	13F	Company	0.01%	8,095	$43,227	—	30 Sep 2024	13F
DEUTSCHE BANK AG\	13F	Company	0.01%	7,332	$39,153	—	30 Sep 2024	13F
UBS Group AG	13F	Company	0.01%	7,156	$38,213	—	30 Sep 2024	13F
JPMORGAN CHASE & CO	13F	Company	0.01%	7,146	$38,160	—	30 Sep 2024	13F
Lawrence A. Kenyon	3/4/5	Chief Financial Officer, Director	— mixed-class rows	18,446 mixed-class rows	$33,828	—	26 Sep 2024	3/4/5
Ancora Advisors LLC	13F	Company	0.01%	6,100	$32,574	—	30 Sep 2024	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	5,570	$29,743	—	30 Sep 2024	13F
OSAIC HOLDINGS, INC.	13F	Company	0%	3,384	$18,071	—	30 Sep 2024	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0%	3,020	$16,127	—	30 Sep 2024	13F

Institutional Holders of Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share (OTLK) as of Q4 2024

As of 31 Dec 2024, Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share (OTLK) was held by 60 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,545,632 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, STATE STREET CORP, RHUMBLINE ADVISERS, TANG CAPITAL MANAGEMENT LLC, FMR LLC, Woodline Partners LP, and RENAISSANCE TECHNOLOGIES LLC. This page lists 60 institutional shareholders reporting positions in this security for the Q4 2024 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders

Q4 2024 holders

Holder diff

-5

Investor	Q3 2024 Shares	Q4 2024 Shares	Share Diff	Share Chg %	Q3 2024 Value $	Q4 2024 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.